GlassScriptPhysician profile
Drahmane Kaba
NPI 1881838340
$22,549.16
in general payments reported to CMS, 2019-2025
45 companies · $4,297 in 2025
The $4,297 reported for 2025 was more than what 89% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,303 · 2020: $911 · 2021: $4,043 · 2022: $1,141 · 2023: $1,843 · 2024: $4,011 · 2025: $4,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,325 · Travel and Lodging: $3,826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,325.16 |
| Travel and Lodging | $3,826.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,569.30 | 2019-2024 | Senza |
| Boston Scientific Corporation | $4,280.83 | 2019-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $3,686.39 | 2021-2025 | Ha Minuteman G3-R |
| Vertiflex, INC. | $1,814.10 | 2019 | |
| Abbott Laboratories | $1,764.05 | 2019-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $1,045.31 | 2020-2023 | Mild Device Kit |
| Mml US, INC. | $858.24 | 2025 | Reactiv8 |
| Curonix LLC | $676.06 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $427.18 | 2019-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $388.29 | 2019-2022 | |
| Medtronic, INC. | $360.35 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Globus Medical, INC. | $291.87 | 2025 | Senza, Vyrsa V1 |
| Nutech Spine, INC. | $241.69 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $220.40 | 2019-2024 | Relistor |
| Allergan, INC. | $213.74 | 2019-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drahmane Kaba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.